Sam Ecker

Sam Ecker's work experience begins in 2013 when they worked as a Financial Analyst at Goldman Sachs for two years. Sam then became a VC Investor at Mithril Capital Management LLC, where they sourced, evaluated, and invested in technology companies from 2015 to 2017.

In 2016, Sam joined Stem, Inc. as a Board Observer for a year.

From 2017 to 2018, Sam worked at Anduril Industries as an Early Employee, managing various projects and company needs. Sam then transitioned to the role of Program Manager from 2018 to 2019, where they focused on product development, project management, and cross-functional team coordination. Lastly, Sam became involved in International Business Development at Anduril from 2019 to 2021, expanding the company's work with allies and growing their international footprint.

Currently, Sam is the Director of Revenue at SmithRx, a company dedicated to reducing drug costs and improving health outcomes through their advanced Pharmacy Benefit Manager technology. Sam joined SmithRx in 2022 and continues to work in this role.

From 2009 to 2013, Sam Ecker attended Stanford University and earned a Bachelor of Science (B.S.) degree in Management Science & Engineering. The information does not specify the start and end years of another period of education at Stanford University, nor the degree or field of study.